These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5454440)

  • 1. [On the clinical trial of disopyramide (Rhythmodan) in the prevention of attacks of supraventricular paroxysmal tachycardia].
    Masini G
    Minerva Med; 1970 Sep; 61(71 Suppl):3748-52. PubMed ID: 5454440
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and therapy of supraventricular paroxysmal tachycardia in ambulatory patients. Results of a multicentric study using disopyramide].
    Rouhi A; Penth B; Adams HJ
    Ther Ggw; 1979 Jun; 118(6):957-69. PubMed ID: 462395
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)].
    Satoh M; Sada T; Kuan-Min S; Kira Y; Sekine I; Okabe F; Ueda A; Ito T; Matsumoto S
    Kokyu To Junkan; 1981 May; 29(5):537-44. PubMed ID: 7313358
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and treatment of cardiac arrhythmias with rhythmodan (disopyramide)].
    Doshchitsin VL; Golovina TN; Osipova TN
    Kardiologiia; 1973 Mar; 13(3):97-101. PubMed ID: 4123833
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of disopyramide phosphate in repetitive paroxysmal ventricular tachycardia].
    Katoh T; Sasaki Y; Tsuda T
    Kokyu To Junkan; 1982 Sep; 30(9):959-64. PubMed ID: 7178700
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
    Dzieglielewski T; Wachowiak A
    Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electrophysiological action of disopyramide].
    Grosu AA; Malakhov VI; Smetnev AS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):51-5. PubMed ID: 7138657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of intravenous disopyramide on induction and termination of paroxysmal supraventricular tachycardia via an accessory pathway].
    Komatsu C; Ishinaga T; Tateishi O; Tokuhisa Y; Hara M; Sanada T; Kanae K; Satoh Y; Yoshimura S
    Kokyu To Junkan; 1984 Apr; 32(4):409-14. PubMed ID: 6463419
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of supraventricular paroxysmal tachycardia with cordarone].
    Orlova VP; Kalvelis AD; Raĭbart IaIa
    Sov Med; 1984; (9):73-5. PubMed ID: 6505825
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of paroxysmal supraventricular tachycardia and tachyarrhythmia with verapamil].
    Penkov N; Penev A; Kaponov Kh
    Vutr Boles; 1984; 23(1):63-9. PubMed ID: 6730453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in the use of the new Soviet preparation Amorphin (Fruticin) for the prevention of attacks of paroxysmal tachycardia].
    Moiseev SG; Ustinova EZ
    Sov Med; 1967 Dec; 30(12):53-6. PubMed ID: 5606293
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disopyramide (Rhythmodan) in disorders of ventricular excitability].
    Puech P
    Minerva Med; 1970 Sep; 61(71 Suppl):3763-8. PubMed ID: 4195356
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electrocardiographic findings of importance in the genesis of supraventricular paroxysmal tachycardia].
    Ballarino M; Rumolo R; Recalcati P
    Folia Cardiol; 1967; 26(2):62-78. PubMed ID: 6072700
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind trial of disopyramide, procaineamide and digoxin in paroxysmal suptraventricular tachycardia.
    Millar-Craig MW; Raftery EB
    Clin Cardiol; 1979 Jun; 2(3):179-84. PubMed ID: 389512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
    Koshumbaeva KM; Tulenov MT; Belokopit IN
    Klin Med (Mosk); 2002; 80(2):57-60. PubMed ID: 11898726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of Coritrate in the prevention of paroxysmal tachycardia].
    Homola D; Srnová V; Rotrekl J
    Vnitr Lek; 1973 Sep; 19(9):860-5. PubMed ID: 4583399
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with a new anti-arrhythmic agent: disopyramide (Rhythmodan)].
    Ferrari M; Bigi N
    Minerva Med; 1970 Sep; 61(71 Suppl):3728-33. PubMed ID: 5454436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.